Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04994418 · ClinicalTrials.gov registry record · NA
The Impact of Sodium and Fructose on Blood Pressure and Inflammation
A NA study, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT04994418: Completed NA study, sponsored by University of Delaware.
NCT04994418 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04994418, a NA study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The goal of this study is to determine the impact of dietary sodium and fructose on blood pressure and inflammation in young healthy adults.
Primary Outcome
Systolic blood pressure over 24 hours (mmHg)
Interventions
- DIETARY_SUPPLEMENT Recommended sodium and low fructose diet
- DIETARY_SUPPLEMENT High sodium and low fructose diet
- DIETARY_SUPPLEMENT High sodium and high fructose diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2024-04-15 |
| Phase | NA |
What the finished NCT04994418 record still lists
NCT04994418 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Recommended sodium and low fructose diet is the first listed.
NCT04994418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04994418 about?
NCT04994418 is a clinical study titled "The Impact of Sodium and Fructose on Blood Pressure and Inflammation". The goal of this study is to determine the impact of dietary sodium and fructose on blood pressure and inflammation in young healthy adults.
What is the current status of trial NCT04994418?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2021-04-01. Estimated completion is 2024-04-15.
What interventions are being tested in trial NCT04994418?
The interventions under investigation include: Recommended sodium and low fructose diet (DIETARY_SUPPLEMENT), High sodium and low fructose diet (DIETARY_SUPPLEMENT), High sodium and high fructose diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04994418?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04994418's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI